Bør kemoterapi eller endokrin terapi anvendes først hos patienter med fremskreden brystkræft? Statusartikel udarbejdet på baggrund af Cochrane-analysen "Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer"

Bent Ejlertsen, Henning Mouridsen

Bidragets oversatte titelShould chemotherapy or endocrine therapy be used as first choice in patients with advanced breast cancer?: A status article based on the Cochrane analysis "Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer"
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind166
Udgave nummer25
Sider (fra-til)2434-6
Antal sider3
ISSN0041-5782
StatusUdgivet - 14 jun. 2004
Udgivet eksterntJa

Emneord

  • Antineoplastic Agents/adverse effects
  • Antineoplastic Combined Chemotherapy Protocols/adverse effects
  • Breast Neoplasms/drug therapy
  • Estrogen Receptor Modulators/adverse effects
  • Evidence-Based Medicine
  • Female
  • Humans
  • Meta-Analysis as Topic
  • Quality of Life
  • Survival Rate

Citationsformater